The effect of intravitreal bevacizumab in the treatment of Coats disease in children

Retina. 2011 Feb;31(2):427-8; author reply 428. doi: 10.1097/IAE.0b013e318203c01e.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Child, Preschool
  • Diagnosis, Differential
  • Drug Administration Routes
  • Eye Enucleation
  • Female
  • Fluorescein Angiography
  • Humans
  • Intravitreal Injections
  • Retinal Neoplasms / diagnosis*
  • Retinal Neoplasms / surgery
  • Retinal Telangiectasis / diagnosis*
  • Retinal Telangiectasis / drug therapy
  • Retinal Vessels / drug effects
  • Retinal Vessels / pathology*
  • Retinoblastoma / diagnosis*
  • Retinoblastoma / surgery

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab